secwatch.observer — SEC 8-K summary
======================================

Issuer:     EBR Systems, Inc. (EBRCZ)
CIK:        0001347123
Form:       8-K
Filed at:   2025-04-15T23:59:59+00:00
Accession:  0001214659-25-005919
Event type: regulatory
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CMS proposes NTAP reimbursement for EBR's WiSE CRT at max 65% rate
------------------------------------------------------------------

- CMS proposed NTAP for WiSE CRT System for FY 2026 at maximum add-on payment of 65% of device cost.
- NTAP is in addition to standard MS-DRG payment, intended to fully cover device cost.
- NTAP effective from 1 Oct 2025 for three years, subject to final CMS rule expected August 2025.
- EBR plans to apply for Transitional Pass-through reimbursement for outpatients shortly.
- FDA approval of WiSE CRT also announced; both milestones advance US commercialization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347123/000121465925005919/0001214659-25-005919-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347123/000121465925005919/z4152508k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-005919

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer